January 14, 2019 Intelligence: Late Breaking Lab News

By Robert Michel | From the Volume XXVI No. 1 – January 14, 2019 Issue

Up to 10,000 patients will get free genetic testing at Northwell Health, the nation’s largest urban health network. In a deal announced on Jan. 9, Northwell Health and Color, a genetic testing company, will collaborate on a program to offer geneti…

Read More

---

Anthem Launches Program to Manage Genetic Tests

By R. Lewis Dark | From the Volume XXIV No. 9 – June 26, 2017 Issue

CEO SUMMARY: Pre-authorization of genetic tests is coming to physicians serving patients insured by Anthem, Inc. Its specialty benefits management company, AIM Specialty Health, will manage the program. AIM will work with InformedDNA, a company that specializes in genetic testing clinical…

Read More

---

In this Philadelphia Story, LabCorp Uses 2007 Script

By Joseph Burns | From the Volume XXI No. 12 – September 2, 2014 Issue

CEO SUMMARY: There’s a managed care contracting play-book that seems to be working better for Laboratory Corporation of America than it does for Quest Diagnostics Inc. On July 1, LabCorp became the exclusive national lab provider for Independence Blue Cross of Philadelphia. For the past…

Read More

---

Why One Molecular Diagnostics Company Closed Its Doors

By Joseph Burns | From the Volume XX No. 7 – May 28, 2013 Issue

CEO SUMMARY: When executives closed the doors of Pathwork Diagnostics last month, the simple explanation was that reimbursement for its proprietary molecular diagnostic test was inadequate. Indeed, that was part of the story. But other factors played significant roles in impeding…

Read More

---

September 17, 2012 “Intelligence: Late Breaking Lab News”

By Robert Michel | From the Volume XIX No. 13 – September 17, 2012 Issue

Exome sequencing testing for cancer patients is now offered by the Cancer Genetics Laboratory at Baylor College of Medicine (BCM) in Houston, Texas. This clinical testing will be performed using next-generation gene sequencing technology. Pathologists at Baylor are among the first in…

Read More

---

December 19, 2011 “Intelligence: Late Breaking Lab News”

By Robert Michel | From the Volume XVIII No. 17 – December 19, 2011 Issue

Expanded genetic testing for cancer patients in the United Kingdom is one goal of a new effort by the Stratified Medicine Programme at Cancer Research UK. Officials want to ensure that the right genetic tests are available to support use of new therapeutic drugs for …

Read More

---

Baylor Pathologists Form Lab with US Oncology

By Robert Michel | From the Volume XVII No. 4 – March 8, 2010 Issue

CEO SUMMARY: In Dallas, Pathologists Bio-Medical Laboratories is part of a new laboratory partnership that includes Baylor Health Care System, Texas Oncology, and US Oncology. The four partners ponied up a total of $40 million in cash and debt to build a state-of-the art laboratory in a 1…

Read More

---

DeVry University, Retail Walk-In Clinics, NeoGenomics, Clarient, Clinical Lab Partners, Patient ID Theft

By Robert Michel | From the Volume XV No. 13 – September 29, 2008 Issue

MED TECH SHORTAGE CAUSES DEVRY UNIVERSITY TO OFFER MT DEGREE IN RESPONSE TO THE GROWING SHORTAGE of skilled lab scientists and medical technologists, DeVry University of Phoenix, Arizona, is offering a new bachelor’s degree program in Clinical Laboratory Science (…

Read More

---

Oncology Diagnostics Attracts Big Money

By R. Lewis Dark | From the Volume XI No. 4 – March 15, 2004 Issue

MORE SURPRISING DEVELOPMENTS for the anatomic pathology profession during the past three weeks! The impending $215 million acquisition of IMPATH, Inc. by Genzyme Corporation, announced on March 1, has the …

Read More

---

New Competitors Line Up In Oncology Marketplace

By Robert Michel | From the Volume XI No. 4 – March 15, 2004 Issue

CEO SUMMARY: Local pathology groups are advised to more closely track developments in the national market for oncology testing. Not only is big money targeting cancer testing, but a number of nimble, entrepreneurial start-up companies have begun to compete for specimens. Genzyme’s acqui…

Read More

---